跳至主要内容
临床试验/ACTRN12618001846213
ACTRN12618001846213尚未招募不适用

A pilot study examining the association of white blood cell morphology and O-GlcNAcylation with the presence of established type 1 and type 2 diabetes

Baker Heart and Diabetes Institute0 个研究点目标入组 90 人开始时间: 2018年11月14日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Age: 18 - 65 yrs
  • Inclusion criteria;
  • Non-diabetic: any healthy, non-diabetic (normoglycemic) individual
  • Diabetic: Any patients with clinically diagnosed type-1 or type-2 diabetes
  • Informed consent: participant must be able to give personal informed consent
  • Participation in the study: participant must be able to co-operate sufficiently to allow the proposed study to progress.
  • Concomitant medications: no restriction is made in the use of concomitant medications, which will be left to the treating specialist

排除标准

  • 未提供

研究者

相似试验